3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Epstein-Barr Virus Infections
3
Glioblastoma
2
Cytomegalovirus Infections
2
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Solid Tumor, Adult
1
Sezary Syndrome
1
Pyloric Stenosis, Hypertrophic
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Interventions
Matrix-M
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Herpes Simplex
×
Valganciclovir
×
1 year
×
Clear all
No trials found.